Showing results (2011-2020 of 2,186) with videos related to
Sort By:
Pageof 219
Nature Genetics|June 30, 2001
Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemiaZ Ma, S W Morris, V Valentine, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|September 13, 2005
An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor lineYuwei Wang, Hui Xue, Jean-Claude Cutz, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 28, 2020
Contributions of HOX genes to cancer hallmarks: Enrichment pathway analysis and reviewDanielle Barbosa Brotto, Ádamo Davi Diógenes Siena, Isabela Ichihara de Barros, et al.Plos One|May 17, 2011
Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouseJonathon M Tinsley, Rebecca J Fairclough, Richard Storer, et al.Nature Communications|June 21, 2019
Publisher Correction: Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and responseSimon F Merz, Sebastian Korste, Lea Bornemann, et al.Cell Reports|August 17, 2022
During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodesEkaterina Pylaeva, Georg Korschunow, Ilona Spyra, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 11, 2025
Scaling-up symptom-agnostic, community-wide screening toward global tuberculosis elimination: opportunities, challenges, and lessons from historyHanif Esmail, Cecily Miller, Dennis Falzon, et al.Nature Communications|February 12, 2024
Poly-γ-glutamylation of biomoleculesGhader Bashiri, Esther M M Bulloch, William R Bramley, et al.Genes & Development|September 23, 2008
TAp73 knockout shows genomic instability with infertility and tumor suppressor functionsRichard Tomasini, Katsuya Tsuchihara, Margareta Wilhelm, et al.Investigational New Drugs|May 19, 2015
A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195B J Eigl, S North, E Winquist, et al.Pageof 219